Compare MONDELEZ INTERNATIONAL INC Common Stock (MDLZ) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MONDELEZ INTERNATIONAL INC Common Stock vs Medpace Holdings Inc — how do they compare? MONDELEZ INTERNATIONAL INC Common Stock trades at $60.31 (market cap $77.37B), while Medpace Holdings Inc trades at $530.22 (market cap $15.08B). The key difference: MONDELEZ INTERNATIONAL INC Common Stock is far larger — about 5.1× Medpace Holdings Inc's market cap, and MONDELEZ INTERNATIONAL INC Common Stock pays a 3.32% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MDLZ | MEDP | |
|---|---|---|
Market Cap | $77.37B | $15.08B |
Sector | Consumer Staples | Technology |
52-Week High | $70.75 | $620.59 |
52-Week Low | $51.51 | $308.88 |
Enterprise Value | $97.46B | $14.55B |
Dividend Yield | 3.32% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MONDELEZ INTERNATIONAL INC Common Stock
Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack arena with a presence in the biscuit (47% of sales), chocolate (32%), gum/candy (10%), beverage (4%), and cheese and grocery (7%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, Trident, and Cadbury, among others. The firm derives around one third of revenue from developing markets, nearly 40% from Europe, and the remainder from North America.
Read more on MDLZ →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
